Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Postgraduate Medicine
|
October 5, 2017
Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?
John R Nelson, Wayne S True, Viet Le, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Differentiating EPA from EPA/DHA in cardiovascular risk reduction
Peter P Toth, M John Chapman, Klaus G Parhofer, et al.
Journal of the American Chemical Society
|
February 24, 2005
Terminal phosphate-labeled nucleotides with improved substrate properties for homogeneous nucleic acid assays
Anup Sood, Shiv Kumar, Satyam Nampalli, et al.
The Cochrane Database of Systematic Reviews
|
April 25, 2025
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome
Aamer Imdad, John R Nelson, Emily E Tanner-Smith, et al.
Clinical Cardiology
|
January 25, 2018
Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
Matthew Budoff, J Brent Muhlestein, Viet T Le, et al.
Journal of Medical Economics
|
June 29, 2016
A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States
Sephy Philip, Sumita Chowdhury, John R Nelson, et al.
Cardiovascular Diabetology
|
January 23, 2025
Atherogenic index of plasma and coronary artery disease: a systematic review and meta-analysis of observational studies
Ramin Assempoor, Mohammad Shahabaddin Daneshvar, Aryan Taghvaei, et al.
Journal of Clinical Lipidology
|
February 5, 2022
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States
Margaret R Diffenderfer, Nandani Rajapakse, Ericka Pham, et al.
Postgraduate Medicine
|
April 26, 2021
EPA's pleiotropic mechanisms of action: a narrative review
John R Nelson, Matthew J Budoff, Omar R Wani, et al.
Acta Cardiologica
|
August 12, 2025
Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials
John P Sheppard, Suvasini Lakshmanan, Leonard Palatnic, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Postgraduate Medicine
|
October 5, 2017
Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?
John R Nelson, Wayne S True, Viet Le, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Differentiating EPA from EPA/DHA in cardiovascular risk reduction
Peter P Toth, M John Chapman, Klaus G Parhofer, et al.
Journal of the American Chemical Society
|
February 24, 2005
Terminal phosphate-labeled nucleotides with improved substrate properties for homogeneous nucleic acid assays
Anup Sood, Shiv Kumar, Satyam Nampalli, et al.
The Cochrane Database of Systematic Reviews
|
April 25, 2025
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome
Aamer Imdad, John R Nelson, Emily E Tanner-Smith, et al.
Clinical Cardiology
|
January 25, 2018
Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
Matthew Budoff, J Brent Muhlestein, Viet T Le, et al.
Journal of Medical Economics
|
June 29, 2016
A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States
Sephy Philip, Sumita Chowdhury, John R Nelson, et al.
Cardiovascular Diabetology
|
January 23, 2025
Atherogenic index of plasma and coronary artery disease: a systematic review and meta-analysis of observational studies
Ramin Assempoor, Mohammad Shahabaddin Daneshvar, Aryan Taghvaei, et al.
Journal of Clinical Lipidology
|
February 5, 2022
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States
Margaret R Diffenderfer, Nandani Rajapakse, Ericka Pham, et al.
Postgraduate Medicine
|
April 26, 2021
EPA's pleiotropic mechanisms of action: a narrative review
John R Nelson, Matthew J Budoff, Omar R Wani, et al.
Acta Cardiologica
|
August 12, 2025
Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials
John P Sheppard, Suvasini Lakshmanan, Leonard Palatnic, et al.
Page
of 5